Thrivent Financial for Lutherans
CRBU icon

Thrivent Financial for Lutherans’s Caribou Biosciences CRBU Stock Holding History

Thrivent Financial for Lutherans’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,562
Closed -$83K – 2579
2025
Q3 		$83K Sell
35,562
-238,923
-87% -$451K ﹤0.01% 2353
2025
Q2 		$346K Hold
274,485
– – ﹤0.01% 2265
2025
Q1 		$250K Buy
274,485
+87,864
+47% +$114K ﹤0.01% 2271
2024
Q4 		$297K Buy
186,621
+79,636
+74% +$160K ﹤0.01% 2412
2024
Q3 		$210K Hold
106,985
– – ﹤0.01% 2473
2024
Q2 		$175K Buy
+106,985
New +$342K ﹤0.01% 2494

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Thrivent Financial for Lutherans's CRBU Position: Q4 2025 in Review

Thrivent Financial for Lutherans sold out of Caribou Biosciences (CRBU) in Q4 2025, closing a stake of 35,562 shares — an estimated $83K sold.

Thrivent Financial for Lutherans first reported a position in CRBU in Q2 2024 and held it in 6 quarters. The position peaked at $346K in Q2 2025. 124 funds tracked by Wall St. Rank hold CRBU as of Q4 2025.

  • Thrivent Financial for Lutherans reported no remaining Caribou Biosciences position as of Q4 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 35,562 Caribou Biosciences shares in Q4 2025, an estimated $83K.
  • Thrivent Financial for Lutherans first reported a position in Caribou Biosciences in Q2 2024 and held it in 6 quarters.
  • Thrivent Financial for Lutherans's Caribou Biosciences position peaked at $346K in Q2 2025.
  • 124 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2025, filed 5 Feb 2026.